New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Singular Genomics Systems, Inc.
OMIC
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

38M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

38M

Medical - Instruments & Supplies

Next Earning date - 12 Nov 2024

15.38USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-65%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

22%

Quote Panel

Shape
Updated October 3, 2024
1W -0.71 % 1M 149.68 % 3M 93.70 % 1Y 38.43 %

Key Metrics

Shape
  • Market Cap

    38.38M


  • Shares Outstanding

    2.50M


  • Share in Float

    1.48M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    15.38


  • Average Volume

    96115


  • Beta

    1.349


  • Range

    5.34-19.8


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://singulargenomics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

14.10x

P/S Ratio

0.28x

P/B Ratio

0.1

Debt/Equity

-3375.7%

Net Margin

$-37.3

EPS

How OMIC compares to sector?

P/E Ratio

Relative Strength

Shape

OMIC

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$10M

Shape1277%

2025-Revenue

$31.72

Shape-270%

2025-EPS

$2M

Shape109%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

downgrade

Previous: Not converted

2022-08-17

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-9.91
vs -7.51

Q4.22

arrow
arrow

N/A

-8.71
vs -8.11

Q1.23

arrow
arrow

N/A

-9.91
vs -9.31

Q2.23

arrow
arrow

N/A

-10.51
vs -10.21

Q3.23

arrow
arrow

N/A

-9.31
vs -9.91

Q4.23

arrow
arrow

N/A

-9.61
vs -8.71

Q1.24

arrow
arrow

N/A

-10.21
vs -9.91

Q2.24

arrow
arrow

N/A

-8.57
vs -10.51

Q3.24

arrow
arrow

N/A

-8.24
vs -9.31

Q4.24

arrow
arrow

N/A

-8.18
vs -9.61

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

765K  vs NA

Q1.23

arrow
arrow

NA

863K  vs NA

Q2.23

arrow
arrow

NA

505K  vs NA

Q3.23

arrow
arrow

NA

462K  vs NA

Q4.23

arrow
arrow

+41%

1.1M  vs 765K

Q1.24

arrow
arrow

-49%

442K  vs 863K

Q2.24

arrow
arrow

+46%

737K  vs 505K

Q3.24

arrow
arrow

+106%

950K  vs 462K

Q4.24

arrow
arrow

+64%

1.8M  vs 1.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.08

Q4.22

arrow
arrow

-8%

-0.08
vs -0.08

Q1.23

arrow
arrow

-9%

-0.09
vs -0.08

Q2.23

arrow
arrow

-12%

-0.12
vs -0.09

Q3.23

arrow
arrow

-11%

-0.11
vs -0.12

Q4.23

arrow
arrow

-13%

-0.13
vs -0.11

Q1.24

arrow
arrow

-16%

-0.16
vs -0.13

Q2.24

arrow
arrow

-15%

-0.15
vs -0.16

Institutionnal OwnershipShape

status-upQoQ

Q2.22

arrow
arrow

75

75
vs 69

9%

Q3.22

arrow
arrow

71

71
vs 75

-5%

Q4.22

arrow
arrow

80

80
vs 71

13%

Q1.23

arrow
arrow

67

67
vs 80

-16%

Q2.23

arrow
arrow

62

62
vs 67

-7%

Q3.23

arrow
arrow

48

48
vs 62

-23%

Q4.23

arrow
arrow

47

47
vs 48

-2%

Q1.24

arrow
arrow

43

43
vs 47

-9%

Earnings Growth

Latest News